The influence of pre-admission hypoglycaemic therapy on cardiac morbidity and mortality in type 2 diabetic patients undergoing major non-cardiac surgery: A prospective observational study

Anaesthesia

Volumn 67, Issue 2, 2012, Pages 149-157

  Bolliger, D ^a   Seeberger, M D ^a   Lurati Buse, G ^a   Christen, P ^b   Seeberger, E ^a   Ruppen, W ^a   Filipovic, M ^c  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b LUZERNER KANTONSSPITAL   (Switzerland)

^c CANTONAL HOSPITAL ST GALLEN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; BIGUANIDE; INSULIN; MEGLITINIDE; ORAL ANTIDIABETIC AGENT; SULFONYLUREA;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; COHORT ANALYSIS; DIABETIC PATIENT; DRUG THERAPY; FEMALE; HUMAN; LAPAROTOMY; MAJOR CLINICAL STUDY; MAJOR SURGERY; MALE; MORBIDITY; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBSERVATIONAL STUDY; ORTHOPEDIC SURGERY; PREADMISSION HYPOGLYCEMIC THERAPY; PROSPECTIVE STUDY; THORACOTOMY; VASCULAR SURGERY;

ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; BLOOD GLUCOSE; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; ENDPOINT DETERMINATION; FEMALE; HEART DISEASES; HUMANS; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; POSTOPERATIVE PERIOD; PROSPECTIVE STUDIES; RISK ASSESSMENT; SURGICAL PROCEDURES, OPERATIVE; VASCULAR SURGICAL PROCEDURES;

EID: 84856007820     PISSN: 00032409     EISSN: 13652044     Source Type: Journal    
DOI: 10.1111/j.1365-2044.2011.06963.x     Document Type: Article

References (39)

1. Akhtar S, Barash PG, Inzucchi SE,. Scientific principles and clinical implications of peri-operative glucose regulation and control. Anesthesia and Analgesia 2010; 110: 478-97.
2. Goldfine AB, Beckman JA,. Life and death in Denmark: lessons about diabetes and coronary heart disease. Circulation 2008; 117: 1914-7. (Pubitemid 351543466)
3. Weiser TG, Regenbogen SE, Thompson KD, et al., An estimation of the global volume of surgery: a modelling strategy based on available data. Lancet 2008; 372: 139-44.
4. Buse JB, Ginsberg HN, Bakris GL, et al., Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association. Circulation 2007; 115: 114-26. (Pubitemid 46058619)
5. Fleisher LA, Beckman JA, Brown KA, et al., 2009 ACCF/AHA focused update on peri-operative beta blockade incorporated into the ACC/AHA 2007 guidelines on peri-operative cardiovascular evaluation and care for non-cardiac surgery: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines. Circulation 2009; 120: e169-276.
6. Lee TH, Marcantonio ER, Mangione CM, et al., Derivation and prospective validation of a simple index for prediction of cardiac risk of major non-cardiac surgery. Circulation 1999; 100: 1043-9. (Pubitemid 29416229)
7. Zeller M, Danchin N, Simon D, et al., Impact of type of preadmission sulfonylureas on mortality and cardiovascular outcomes in diabetic patients with acute myocardial infarction. Journal of Clinical Endocrinology and Metabolism 2010; 95: 4993-5002.
8. Jeger RV, Seeberger MD, Keller U, Pfisterer ME, Filipovic M,. Oral hypoglycemics: increased postoperative mortality in coronary risk patients. Cardiology 2007; 107: 296-301. (Pubitemid 46788247)
9. Langley J, Adams G,. Insulin-based regimens decrease mortality rates in critically ill patients: a systematic review. Diabetes/Metabolism Research and Reviews 2007; 23: 184-92. (Pubitemid 46437843)
10. Malmstedt J, Wahlberg E, Jorneskog G, Swedenborg J,. Influence of peri-operative blood glucose levels on outcome after infrainguinal bypass surgery in patients with diabetes. British Journal of Surgery 2006; 93: 1360-7. (Pubitemid 44736086)
11. Noordzij PG, Boersma E, Schreiner F, et al., Increased pre-operative glucose levels are associated with peri-operative mortality in patients undergoing non-cardiac, non-vascular surgery. European Journal of Endocrinology 2007; 156: 137-42. (Pubitemid 46553914)
12. Ouattara A, Lecomte P, Le Manach Y, et al., Poor intra-operative blood glucose control is associated with a worsened hospital outcome after cardiac surgery in diabetic patients. Anesthesiology 2005; 103: 687-94. (Pubitemid 41415516)
13. van den Berghe G, Wouters P, Weekers F, et al., Intensive insulin therapy in the critically ill patients. New England Journal of Medicine 2001; 345: 1359-67.
14. Peduzzi P, Concato J, Kemper E, Holford TR, Feinstein AR,. A simulation study of the number of events per variable in logistic regression analysis. Journal of Clinical Epidemiology 1996; 49: 1373-9. (Pubitemid 27028925)
15. Bolliger D, Seeberger MD, Lurati Buse GA, Christen P, Gurke L, Filipovic M,. Randomized clinical trial of moxonidine in patients undergoing major vascular surgery. British Journal of Surgery 2007; 94: 1477-84. (Pubitemid 350275625)
16. Bolliger D, Seeberger MD, Lurati Buse GA, et al., A preliminary report on the prognostic significance of pre-operative brain natriuretic peptide and postoperative cardiac troponin in patients undergoing major vascular surgery. Anesthesia and Analgesia 2009; 108: 1069-75.
17. Ubink-Veltmaat LJ, Bilo HJ, Groenier KH, Houweling ST, Rischen RO, Meyboom-de Jong B,. Prevalence, incidence and mortality of type 2 diabetes mellitus revisited: a prospective population-based study in the Netherlands (ZODIAC-1). European Journal of Epidemiology 2003; 18: 793-800. (Pubitemid 37039978)
18. Bolsin SN, Raineri F, Lo SK, Cattigan C, Arblaster R, Colson M,. Cardiac complications and mortality rates in diabetic patients following non-cardiac surgery in an Australian teaching hospital. Anaesthesia and Intensive Care 2009; 37: 561-7.
19. Krolikowska M, Kataja M, Poyhia R, Drzewoski J, Hynynen M,. Mortality in diabetic patients undergoing non-cardiac surgery: a 7-year follow-up study. Acta Anaesthesiologica Scandinavica 2009; 53: 749-58.
20. Juul AB, Wetterslev J, Gluud C, et al., Effect of peri-operative beta blockade in patients with diabetes undergoing major non-cardiac surgery: randomised placebo controlled, blinded multicentre trial. British Medical Journal 2006; 332: 1482.
21. O'Neil-Callahan K, Katsimaglis G, Tepper MR, et al., Statins decrease peri-operative cardiac complications in patients undergoing non-cardiac vascular surgery: the Statins for Risk Reduction in Surgery (StaRRS) study. Journal of the American College of Cardiology 2005; 45: 336-42. (Pubitemid 40186781)
22. Choi JH, Cho DK, Song YB, et al., Preoperative NT-proBNP and CRP predict peri-operative major cardiovascular events in non-cardiac surgery. Heart 2010; 96: 56-62.
23. Zethelius B, Berglund L, Sundstrom J, et al., Use of multiple biomarkers to improve the prediction of death from cardiovascular causes. New England Journal of Medicine 2008; 358: 2107-16. (Pubitemid 351679597)
24. Albacker T, Carvalho G, Schricker T, Lachapelle K,. High-dose insulin therapy attenuates systemic inflammatory response in coronary artery bypass grafting patients. Annals of Thoracic Surgery 2008; 86: 20-7.
25. Ljungqvist O, Nygren J, Thorell A,. Insulin resistance and elective surgery. Surgery 2000; 128: 757-60.
26. Kosiborod M, Inzucchi SE, Krumholz HM, et al., Glucometrics in patients hospitalized with acute myocardial infarction: defining the optimal outcomes-based measure of risk. Circulation 2008; 117: 1018-27.
27. Robertshaw HJ, Hall GM,. Diabetes mellitus: anaesthetic management. Anaesthesia 2006; 61: 1187-90. (Pubitemid 44697858)
28. Joshi GP, Chung F, Vann MA, et al., Society for Ambulatory Anaesthesia consensus statement on peri-operative blood glucose management in diabetic patients undergoing ambulatory surgery. Anesthesia and Analgesia 2010; 111: 1378-87.
29. Gandhi GY, Nuttall GA, Abel MD, et al., Intensive intraoperative insulin therapy vs conventional glucose management during cardiac surgery: a randomized trial. Annals of Internal Medicine 2007; 146: 233-43. (Pubitemid 351650609)
30. Wiener RS, Wiener DC, Larson RJ,. Benefits and risks of tight glucose control in critically ill adults: a meta-analysis. Journal of the American Medical Association 2008; 300: 933-44.
31. Finfer S, Chittock DR, Su SY, et al., Intensive vs conventional glucose control in critically ill patients. New England Journal of Medicine 2009; 360: 1283-97.
32. Arabi YM, Dabbagh OC, Tamim HM, et al., Intensive vs conventional insulin therapy: a randomized controlled trial in medical and surgical critically ill patients. Critical Care Medicine 2008; 36: 3190-7.
33. Brunkhorst FM, Engel C, Bloos F, et al., Intensive insulin therapy and pentastarch resuscitation in severe sepsis. New England Journal of Medicine 2008; 358: 125-39.
34. Gerstein HC, Miller ME, Genuth S, et al., Long-term effects of intensive glucose lowering on cardiovascular outcomes. New England Journal of Medicine 2011; 364: 818-28.
35. Engler RL, Yellon DM,. Sulfonylurea KATP blockade in type II diabetes and preconditioning in cardiovascular disease. Time for reconsideration. Circulation 1996; 94: 2297-301. (Pubitemid 26360527)
36. Meinert CL, Knatterud GL, Prout TE, Klimt CR,. A study of the effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. II. Mortality results. Diabetes 1970; 19 (Suppl): 789-830.
37. Kahn SE, Haffner SM, Heise MA, et al., Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy. New England Journal of Medicine 2006; 355: 2427-43. (Pubitemid 44903747)
38. Egi M, Bellomo R, Stachowski E, French CJ, Hart G,. Variability of blood glucose concentration and short-term mortality in critically ill patients. Anesthesiology 2006; 105: 244-52. (Pubitemid 44148168)
39. Redfern G, Rodseth RN, Biccard BM,. Outcomes in vascular surgical patients with isolated postoperative troponin leak: a meta-analysis. Anaesthesia 2011; 66: 604-10.